FFL
BNTX icon

Financial Freedom LLC’s BioNTech BNTX Stock Holding History

Financial Freedom LLC’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$546 – 381
2023
Q2 		$546 Hold
5
– – ﹤0.01% 390
2023
Q1 		$631 Hold
5
– – ﹤0.01% 383
2022
Q4 		$760 Buy
+5
New +$769 ﹤0.01% 379

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Financial Freedom LLC's BNTX Position: Q3 2023 in Review

Financial Freedom LLC sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 5 shares — an estimated $546 sold.

Financial Freedom LLC first reported a position in BNTX in Q4 2022 and held it in 3 quarters. The position peaked at $760 in Q4 2022. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

  • Financial Freedom LLC reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
  • Financial Freedom LLC sold 5 BioNTech shares in Q3 2023, an estimated $546.
  • Financial Freedom LLC first reported a position in BioNTech in Q4 2022 and held it in 3 quarters.
  • Financial Freedom LLC's BioNTech position peaked at $760 in Q4 2022.
  • 252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Financial Freedom LLC's 13F filing for Q3 2023, filed 6 Nov 2023.